drugset / Trial / NCT00574119

Effect of Aldosterone on Energy Starvation in Heart Failure

NCT00574119

Phase 4 Completed 16 enrolled Vanderbilt University
NaSingle-groupOpen-labelDiagnostic

Summary

We plan to study the concept of "energy starvation" in heart failure by evaluation of patients with nonischemic dilated cardiomyopathy (NIDCM) (heart failure with reduced heart pump function due to causes other than heart attack). We will use a combination of positron emission tomography and magnetic resonance imaging to study metabolism, anatomy, function, blood flow and efficiency, before and after 6 months' treatment with the drug spironolactone which blocks the deleterious effects of the hormone aldosterone on the myocardium (heart muscle).

Timeline

Start
2007-12
Primary completion
2012-07
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Spironolactone Small molecule 50 mg